Recombinant multi-species CALM2/CALM protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CALM2/CALM protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene is a member of the calmodulin gene family. There are three distinct calmodulin genes dispersed throughout the genome that encode the identical protein, but differ at the nucleotide level. Calmodulin is a calcium binding protein that plays a role in signaling pathways, cell cycle progression and proliferation. Several infants with severe forms of long-QT syndrome (LQTS) who displayed life-threatening ventricular arrhythmias together with delayed neurodevelopment and epilepsy were found to have mutations in either this gene or another member of the calmodulin gene family (PMID:23388215). Mutations in this gene have also been identified in patients with less severe forms of LQTS (PMID:24917665), while mutations in another calmodulin gene family member have been associated with catecholaminergic polymorphic ventricular tachycardia (CPVT)(PMID:23040497), a rare disorder thought to be the cause of a significant fraction of sudden cardiac deaths in young individuals. Pseudogenes of this gene are found on chromosomes 10, 13, and 17. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2015]
The Alternative Names of target: 1500001E21Rik,CALM,CALM2,CALM3,CALML2,CAM1,CAM3,CAMC,CAMII,CAMIII,CaMII,Calm2,Calmodulin-2,Cam,Cam2,CamC,Camb,LQT15,PHKD,PHKD2,caM,calmodulin
Go
to CALM2/CALM products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T39610-Ag-1/ GM-Tg-hg-T39610-Ag-2 | Human CALM2/CALM protein | Human |
| GM-Tg-rg-T39610-Ag-1/ GM-Tg-rg-T39610-Ag-2 | Rat CALM2/CALM protein | Rat |
| GM-Tg-mg-T39610-Ag-1/ GM-Tg-mg-T39610-Ag-2 | Mouse CALM2/CALM protein | Mouse |
| GM-Tg-cynog-T39610-Ag-1/ GM-Tg-cynog-T39610-Ag-2 | Cynomolgus/Rhesus macaque CALM2/CALM protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T39610-Ag-1/ GM-Tg-felg-T39610-Ag-2 | Feline CALM2/CALM protein | Feline |
| GM-Tg-cang-T39610-Ag-1/ GM-Tg-cang-T39610-Ag-2 | Canine CALM2/CALM protein | Canine |
| GM-Tg-bovg-T39610-Ag-1/ GM-Tg-bovg-T39610-Ag-2 | Bovine CALM2/CALM protein | Bovine |
| GM-Tg-equg-T39610-Ag-1/ GM-Tg-equg-T39610-Ag-2 | Equine CALM2/CALM protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T39610-Ag-1/ GM-Tg-hg-T39610-Ag-2;
GM-Tg-rg-T39610-Ag-1/ GM-Tg-rg-T39610-Ag-2;
GM-Tg-mg-T39610-Ag-1/ GM-Tg-mg-T39610-Ag-2; GM-Tg-cynog-T39610-Ag-1/ GM-Tg-cynog-T39610-Ag-2; GM-Tg-felg-T39610-Ag-1/ GM-Tg-felg-T39610-Ag-2; GM-Tg-cang-T39610-Ag-1/ GM-Tg-cang-T39610-Ag-2; GM-Tg-bovg-T39610-Ag-1/ GM-Tg-bovg-T39610-Ag-2; GM-Tg-equg-T39610-Ag-1/ GM-Tg-equg-T39610-Ag-2 |
| Products Name | CALM2/CALM protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | CALM2/CALM |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CALM2/CALM protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.